Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

NCT00304629 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: galantamine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.